296 related articles for article (PubMed ID: 8422715)
1. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
O'Malley JP; Ziessman HA; Chantarapitak N
Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
[TBL] [Abstract][Full Text] [Related]
2. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
[TBL] [Abstract][Full Text] [Related]
3. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
Taylor A; Ziffer JA; Eshima D
Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
[TBL] [Abstract][Full Text] [Related]
6. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
8. Using the "integral spleen" method of radiorenogram analysis and a baboon model to compare the diagnostic usefulness of technetium-99m-diethylenetriamine pentaacetic acid to that of various technetium-99m-mercaptoacetyltriglycene formulations and iodine-123-hippuran.
Dormehl IC; Van Wyk A; Pilloy W; Maree M; Knoesen O; De Winter R; Jacobs L; Hoppe HC
Am J Physiol Imaging; 1989; 4(1):23-7. PubMed ID: 2522307
[TBL] [Abstract][Full Text] [Related]
9. Significance of early tubular extraction in the first minute of Tc-99m MAG3 renal transplant scintigraphy.
Lin E; Alavi A
Clin Nucl Med; 1998 Apr; 23(4):217-22. PubMed ID: 9554192
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Tc-99m MAG3 and Tc-99m DTPA scintigraphy in neonates.
Taylor A; Clark S; Ball T
Clin Nucl Med; 1994 Jul; 19(7):575-80. PubMed ID: 7924094
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
12. Comparison of technetium-99m MAG3 with iodine-131 hippuran by a simultaneous dual channel technique.
Russell CD; Thorstad B; Yester MV; Stutzman M; Baker T; Dubovsky EV
J Nucl Med; 1988 Jul; 29(7):1189-93. PubMed ID: 2969040
[TBL] [Abstract][Full Text] [Related]
13. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 May; 19(5):446-51. PubMed ID: 8039322
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 Apr; 19(4):314-20. PubMed ID: 8004863
[TBL] [Abstract][Full Text] [Related]
16. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3.
Rossleigh MA; Thomas MY; Moase AL
Clin Nucl Med; 1994 Oct; 19(10):880-2. PubMed ID: 7805322
[TBL] [Abstract][Full Text] [Related]
17. Background correction in estimating initial renal uptake. Comparison between Tc-99m MAG3 and Tc-99m DTPA.
Inoue Y; Machida K; Honda N; Takahashi T; Mamiya T
Clin Nucl Med; 1994 Dec; 19(12):1049-54. PubMed ID: 7874800
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of renal function with technetium-99m MAG3.
Russell CD; Thorstad BL; Yester MV; Stutzman M; Dubovsky EV
J Nucl Med; 1988 Dec; 29(12):1931-3. PubMed ID: 2973517
[TBL] [Abstract][Full Text] [Related]
19. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
20. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
